Antiretroviral Pre-Exposure Prophylaxis Does Not Enhance Immune Responses to HIV in Exposed but Uninfected Persons

Background. Antiretroviral preexposure prophylaxis (PrEP), using daily oral combination tenofovir disoproxil fumarate plus emtricitabine, is an effective human immunodeficiency virus (HIV) prevention strategy for populations at high risk of HIV acquisition. Although the primary mode of action for th...

Full description

Saved in:
Bibliographic Details
Published in:J Infect Dis
Main Authors: Pattacini, Laura, Murnane, Pamela M., Baeten, Jared M., Fluharty, Tayler R., Thomas, Katherine K., Bukusi, Elizabeth, Katabira, Elly, Mugo, Nelly, Donnell, Deborah, Lingappa, Jairam R., Celum, Connie, Marzinke, Mark, McElrath, M. Juliana, Lund, Jennifer M.
Format: Artigo
Language:Inglês
Published: Oxford University Press 2015
Subjects:
Major Articles and Brief Reports
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4836720/
https://ncbi.nlm.nih.gov/pubmed/25520426
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiu815
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items